Skip to main content
logo
Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
3.230
+0.330 (11.38%)
At close: Aug 6, 2026, 4:00 PM EDT
3.250
+0.020 (0.62%)
Pre-market: Aug 7, 2026, 7:55 AM EDT

Quantum BioPharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-14.87-15.3-16.14-19.23-27.43-33.74
Net Income
-31.16-26.18-14.2-17.9-23.61-35.29
Earnings Per Share
-8.22-7.97-12.49-29.39-39.62-65.63
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4.562.367.23.5116.9835.42
Total Debt
0.871.880.820.340.520.56
Net Cash (Debt)
3.690.496.373.1716.4634.86
Net Cash Growth
63.56%-92.34%100.80%-80.72%-52.77%104.90%
Net Cash Per Share
0.970.155.615.2127.6364.84

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5.64-8.24-6.88-10.83-28.33-20.75
Capital Expenditures
-----0.11-
Free Cash Flow
-5.64-8.24-6.88-10.83-28.45-20.75
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Selected indicators aren't available for this stock.